Loading…
Loading…
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for AWRE and 80,000+ other tickers.
See exactly how AWRE's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for AWRE and 80,000+ other tickers.
Aware, Inc. stands as a global purveyor of biometric software solutions and products, with its operations spanning the United States, Brazil, the United Kingdom, and numerous other international markets. The company's comprehensive product line features specialized biometric software development kits (SDKs) tailored for functions such as biometric search, matching, and enrollment, complemented by powerful application programming interfaces (APIs). Furthermore, Aware delivers advanced imaging tools, notably its JPEG2000 offering, designed to facilitate the compression, storage, and display of…
Bit Digital (BTBT) is upgraded to Buy, driven by its pivot from crypto to AI cloud and colocation, with WhiteFiber (WYFI) as its key asset. Q2 revenue beat was due to a non-recurring termination fee; true growth will reflect in 2027 as WhiteFiber's $932.9M backlog is realized. BTBT trades at over a 30% NAV discount, with current market cap ($571M) below the value of its WhiteFiber stake ($821M).
SAN FRANCISCO--(BUSINESS WIRE)--Today, Abridge announced that partner health systems can extend its clinical intelligence agent to every clinician across their organizations, regardless of how that clinician documents visits today. Health systems can make the agent available through the EHR workflow clinicians already use, or on a new mobile and web experience, each connected to the patient's chart as part of a single organizational decision rather than a clinician-by-clinician rollout. “Adopti.
AWRE is reshaping its business around biometric SaaS in second-quarter 2026, as subscription growth and federal demand offset weakness in perpetual licenses.
Aware, Inc. (AWRE) Q2 2026 Earnings Call Transcript
BURLINGTON, Mass., July 29, 2026 (GLOBE NEWSWIRE) -- Aware, Inc. (NASDAQ: AWRE), a global leader in biometric orchestration, today reported financial results for the second quarter ended June 30, 2026.